| 1 |
34334369 | Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting β2-Adrenergic Receptor Agonists. | 2021 Oct |
1 |
| 2 |
29653961 | Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. | 2018 Jul |
2 |
| 3 |
30327561 | Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist. | 2018 Nov |
4 |
| 4 |
28097668 | Detection and pharmacokinetics of salmeterol in thoroughbred horses following inhaled administration. | 2017 Oct |
1 |
| 5 |
28398147 | Salmeterol, a Long-Acting β2-Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis. | 2017 Jul |
2 |
| 6 |
27222010 | Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. | 2016 Aug |
1 |
| 7 |
27885204 | GENETIC INTERACTIONS BETWEEN ADRB2 AND PTGER4 ON RESPONSES TO SALMETEROL OR MONTELUKAST IN JAPANESE PATIENTS WITH MILD PERSISTENT ASTHMA. | 2016 |
2 |
| 8 |
25324048 | Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains. | 2015 Jan |
1 |
| 9 |
25784721 | Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors. | 2015 Jun |
5 |
| 10 |
25799096 | ASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheas. | 2015 |
1 |
| 11 |
26049917 | Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol. | 2015 Jul |
1 |
| 12 |
26051688 | Salmeterol Xinafoate. | 2015 |
1 |
| 13 |
24461901 | Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. | 2014 Jan |
1 |
| 14 |
24561123 | CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β₂-adrenergic receptor. | 2014 Mar 21 |
1 |
| 15 |
24681963 | The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma. | 2014 May |
1 |
| 16 |
24721141 | Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients. | 2014 |
1 |
| 17 |
23302644 | Agonist-induced receptor internalization in Chinese hamster ovary cells stably co-expressing β(1)- and β(2)-adrenergic receptors. | 2013 |
6 |
| 18 |
23375225 | Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: dual β₂-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD. | 2013 Mar 1 |
2 |
| 19 |
23548523 | Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol. | 2013 Mar |
1 |
| 20 |
24228710 | Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. | 2013 Dec 15 |
1 |
| 21 |
22306235 | Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells. | 2012 Apr |
1 |
| 22 |
23131487 | Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone. | 2012 Nov |
1 |
| 23 |
23300522 | Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes. | 2012 |
2 |
| 24 |
21134482 | The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor. | 2011 Apr |
2 |
| 25 |
21306583 | Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms. | 2011 Jun |
1 |
| 26 |
21357659 | Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. | 2011 Jun |
1 |
| 27 |
20003162 | Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells. | 2010 Mar |
1 |
| 28 |
20423350 | Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. | 2010 May |
1 |
| 29 |
20590599 | The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. | 2010 Jul |
1 |
| 30 |
19059194 | Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. | 2009 Feb |
1 |
| 31 |
19201814 | Modulation of epidermal growth factor receptor binding to human airway smooth muscle cells by glucocorticoids and beta2-adrenergic receptor agonists. | 2009 Apr |
1 |
| 32 |
19594756 | Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol. | 2009 Sep |
1 |
| 33 |
19666775 | Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitization in airway smooth muscle. | 2009 Oct |
2 |
| 34 |
19719334 | Salmeterol/fluticasone propionate: a review of its use in asthma. | 2009 |
1 |
| 35 |
19719779 | Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. | 2009 Sep |
1 |
| 36 |
19800676 | Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. | 2009 Dec |
2 |
| 37 |
17901197 | Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. | 2008 Jan |
1 |
| 38 |
17993585 | Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement. | 2008 Jan |
1 |
| 39 |
18512086 | An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine. | 2008 Sep |
3 |
| 40 |
18586957 | Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. | 2008 Sep |
1 |
| 41 |
16980556 | Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. | 2007 Feb |
4 |
| 42 |
17631879 | Combination of fluticasone propionate and salmeterol potentiates the suppression of cigarette smoke-induced IL-8 production by macrophages. | 2007 Sep 24 |
1 |
| 43 |
17846318 | A novel role of the sympatho-adrenergic system in regulating valve calcification. | 2007 Sep 11 |
1 |
| 44 |
16772309 | Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. | 2006 Nov |
1 |
| 45 |
17030231 | Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. | 2006 Oct |
2 |
| 46 |
15655528 | The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. | 2005 Feb |
1 |
| 47 |
16022567 | Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. | 2005 Jul |
1 |
| 48 |
14662724 | Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. | 2004 Jan |
5 |
| 49 |
14678342 | The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. | 2004 Jan |
1 |
| 50 |
15182210 | Redefining treatment in COPD: new directions in bronchodilator therapy. | 2004 |
1 |